The target audience of a conference focusing on Biochemistry, Structural Biology, and Molecular Biology would be a combination of professionals, researchers, and students from these intersecting fields. This interdisciplinary conference would attract individuals with interests in understanding the molecular mechanisms underlying biological processes, with a particular emphasis on the structures of biological molecules and their functions.

The target audience are:

1.    Biochemists: Researchers studying the chemical processes and reactions that occur within living organisms, including the structure and function of biomolecules such as proteins, nucleic acids, lipids, and carbohydrates.
2.    Structural Biologists: Scientists specializing in determining the three-dimensional structures of biological molecules and macromolecular complexes, using techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and cryo-electron microscopy (cryo-EM).
3.    Molecular Biologists: Professionals investigating the molecular basis of biological phenomena, including gene expression, DNA replication, protein synthesis, and molecular interactions within cells.
4.    Computational Biologists: Researchers employing computational methods and modeling techniques to analyze and predict the structures, functions, and interactions of biological molecules.
5.    Biophysicists: Scientists applying principles of physics to study biological systems, including the physical properties of biomolecules and the dynamics of molecular interactions.
6.    Researchers in Drug Discovery and Development: Professionals involved in identifying and designing compounds for therapeutic purposes, utilizing insights from biochemistry, structural biology, and molecular biology to develop novel drugs and therapies.
7.    Academics: Professors, postdoctoral researchers, and graduate students from universities and research institutions conducting interdisciplinary research at the interface of biochemistry, structural biology, and molecular biology.
8.    Industry Professionals: Scientists, engineers, and executives from biotechnology, pharmaceutical, and biopharmaceutical companies interested in applying interdisciplinary approaches to drug discovery, protein engineering, and molecular diagnostics.
9.    Government Representatives: Officials from government agencies funding research in biochemistry, structural biology, molecular biology, and related fields, as well as regulators overseeing the development and commercialization of biotechnological and pharmaceutical products.
10.    Students: Undergraduate and graduate students pursuing degrees in biochemistry, molecular biology, structural biology, biophysics, computational biology, and related disciplines, seeking to gain insights into cutting-edge research and potential career opportunities.

This conference would provide a platform for interdisciplinary collaboration, knowledge exchange, and networking among researchers and professionals with diverse expertise, addressing topics such as biomolecular structure-function relationships, molecular mechanisms of disease, drug discovery, and emerging technologies in structural and molecular biology.